Tumor Response and Progression-Free Survival as Potential Surrogate Endpoints for Overall Survival in Extensive-Stage Small Cell Lung Cancer (ES-SCLC): Findings Based on North Central Cancer Treatment Group (NCCTG) Trials
      QxMD      Google Scholar   
Citation:
Cancer vol 117 (6) 1262-1271
Year:
2011
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
Yes
Book Volume:
Parents:
557   564   731  
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA025224, U10 CA025224-26, CA25, 224  
Corr. Author:
 
Authors:
                     
Networks:
 
Study
NCCTG-N0424
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
Keywords:
extensive-stage small cell lung cancer, surrogate endpoints, pooled analysis, progression-free survival, tumor response